细胞内环核β1肾上腺素能受体在信号区室化与病理性心脏重构中的独特作用
该研究探讨了细胞内环核β1肾上腺素能受体(β1AR)在信号区室化和病理性心脏重构中的功能。通过活细胞成像和大鼠/人心肌细胞实验,发现高尔基体膜上面向外核膜的β1AR调控含A激酶锚定蛋白6β信号体的环核cAMP区室,选择性调节环核PKA活性,且足以和必要激活钙调磷酸酶-NFAT通路和心肌细胞肥大。在体实验表明,激活环核βAR可诱导扩张型心肌病,而抑制则可改善家族性扩张型心肌病小鼠的心脏功能并抑制病理性重构。
要点
- 环核β1AR位于高尔基体膜上面向外核膜,独立于质膜和内体βAR调控环核cAMP区室。
- 环核βAR足以和必要激活钙调磷酸酶-NFAT通路及心肌细胞肥大。
- 选择性抑制环核βAR可改善家族性扩张型心肌病小鼠已建立疾病的心脏功能并抑制重构。
核心结论
- 环核β1AR调控A激酶锚定蛋白6β信号体,是诱导病理性心脏重构所必需的,构成了一个细胞内纳米区室。
- 为家族性扩张型心肌病提供了新型治疗概念验证,可能适用于其他心血管疾病。
研究设计与样本
- 研究采用大鼠和人心肌细胞活细胞成像,表达区室特异性βAR活性调节剂和荧光生物传感器。
- 在野生型小鼠和家族性扩张型心肌病小鼠模型中,通过腺相关病毒递送实现环核βAR活性的增益和缺失。
主要发现
- 环核β1AR选择性调控环核cAMP依赖性蛋白激酶活性,独立于质膜或内体βAR。
- A激酶锚定蛋白6β区室为纳米尺度,依赖cAMP扩散的局部限制。
- 环核βAR足以和必要激活Ca2+依赖性钙调磷酸酶-NFAT通路和体外心肌细胞肥大。
- AAV9递送外核膜定位的pepducin激活环核βAR,在野生型小鼠中诱导扩张型心肌病。
- AAV递送外核膜定位的纳米抗体抑制环核βAR,改善家族性扩张型心肌病小鼠的心脏功能并抑制病理性重构。
临床怎么用
- 环核βAR信号轴可能成为家族性扩张型心肌病及其他心血管疾病的治疗靶点。
- 选择性抑制环核βAR的策略在已建立疾病的小鼠模型中显示改善心脏功能并抑制重构。
局限性
- 研究主要基于大鼠和人心肌细胞体外实验及小鼠在体模型,尚未在人体中验证。
- 临床转化仍需进一步评估环核βAR靶向治疗的安全性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: β-Adrenergic receptors (βARs) are prototypical G protein-coupled receptors that regulate contractility in the normal heart and pathological remodeling in disease. Canonical βAR signaling originates at the plasma membrane, but functional βARs have been localized to intracellular membranes such as the endosome, sarcoplasmic reticulum, Golgi, and nuclear envelope. The functional significance of these intracellular receptors remains unclear, including whether they regulate cellular processes distinct from those regulated by plasma membrane receptors and whether they can be independently targeted for therapeutic benefit. METHODS: Live cell imaging of rat and human cardiomyocytes expressing novel compartment-specific modulators of βAR activity and fluorescent biosensors was used to study the compartment-specific βAR regulation of second messengers and to target enzyme activity. Compartmentalized signaling was compared with myocyte gene expression and hypertrophy. Adeno-associated virus gene delivery conferring gain and loss of perinuclear βAR activity was studied in wild-type mice and a mouse model of familial dilated cardiomyopathy. RESULTS: We demonstrate here that intracellular β1ARs present on Golgi membrane facing the outer nuclear membrane regulate a perinuclear cAMP compartment containing the A-kinase anchoring protein 6β signalosome, conferring selective regulation of perinuclear cAMP-dependent protein kinase activity independently of βARs at the plasma membrane or endosome. The A-kinase anchoring protein 6β compartment is shown to be of nanometer scale and dependent on local restriction of cAMP diffusion. In addition, perinuclear βARs are shown to be sufficient and necessary for activation of the Ca2+-dependent calcineurin-nuclear factor of activated T cells pathway and myocyte hypertrophy in vitro. Accordingly, adeno-associated virus 9-based delivery of an outer nuclear membrane-localized pepducin, which selectively activated perinuclear βARs in vitro, induced dilated cardiomyopathy in wild-type mice. Conversely, in vivo delivery of an outer nuclear membrane-localized nanobody, which selectively inhibited perinuclear βARs in vitro, improved cardiac function and inhibited pathological remodeling in a mouse model of familial dilated cardiomyopathy with established disease. CONCLUSIONS: These results demonstrate that β1ARs localized to Golgi membranes facing the outer nuclear membrane regulate A-kinase anchoring protein 6β signalosomes required for the induction of pathological cardiac remodeling, defining an intracellular nanocompartment. Proof of concept is provided for a novel therapeutic approach for familial dilated cardiomyopathy, with potential application to other forms of cardiovascular disease.
引用
- Turcotte MG, Samuelsson AM, Possidento SM, et al. Unique Role of Intracellular Perinuclear β1-Adrenergic Receptors in Defining Signaling Compartmentation and Pathological Cardiac Remodeling. Circulation. 2025. PMID: 40665895. doi:10.1161/CIRCULATIONAHA.124.072682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。